Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 4 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Applying HDACis to increase SSTR2 expression and radiolabeled DOTA-TATE uptake: from cells to mice.
Life Sci. 2023 Dec 1;334:122173. doi: 10.1016/j.lfs.2023.122173. Epub 2023 Oct 29.
Life Sci. 2023.
PMID: 37907154
Free article.
GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches.
Verhoeven M, Ruigrok EAM, van Leenders GJLH, van den Brink L, Balcioglu HE, van Weerden WM, Dalm SU.
Verhoeven M, et al. Among authors: van den brink l.
Front Oncol. 2023 Aug 31;13:1199432. doi: 10.3389/fonc.2023.1199432. eCollection 2023.
Front Oncol. 2023.
PMID: 37719014
Free PMC article.
Item in Clipboard
The Effect of VPA Treatment on Radiolabeled DOTATATE Uptake: Differences Observed In Vitro and In Vivo.
Klomp MJ, Hofland LJ, van den Brink L, van Koetsveld PM, Dogan F, de Ridder CMA, Stuurman DC, Clahsen-van Groningen MC, de Jong M, Dalm SU.
Klomp MJ, et al. Among authors: van den brink l.
Pharmaceutics. 2022 Jan 12;14(1):173. doi: 10.3390/pharmaceutics14010173.
Pharmaceutics. 2022.
PMID: 35057069
Free PMC article.
Item in Clipboard
Pre- and Intraoperative Visualization of GRPR-Expressing Solid Tumors: Preclinical Profiling of Novel Dual-Modality Probes for Nuclear and Fluorescence Imaging.
Verhoeven M, Handula M, van den Brink L, de Ridder CMA, Stuurman DC, Seimbille Y, Dalm SU.
Verhoeven M, et al. Among authors: van den brink l.
Cancers (Basel). 2023 Apr 5;15(7):2161. doi: 10.3390/cancers15072161.
Cancers (Basel). 2023.
PMID: 37046825
Free PMC article.
Item in Clipboard
Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer.
Murce E, Spaan E, Beekman S, van den Brink L, Handula M, Stuurman D, de Ridder C, Dalm SU, Seimbille Y.
Murce E, et al. Among authors: van den brink l.
Pharmaceuticals (Basel). 2023 Jul 28;16(8):1072. doi: 10.3390/ph16081072.
Pharmaceuticals (Basel). 2023.
PMID: 37630990
Free PMC article.
Item in Clipboard
Cite
Cite